Fundamental and clinical evaluation of cefozopran in low birth weight infants and neonates

Japanese Journal of Antibiotics

Volumn 50, Issue 12, 1997, Pages 37-39

  Sato, Yoshitake ^a,f   Sunakawa, Keisuke ^b   Akita, Hironobu ^c   Iwata, Satoshi ^d   Yokota, Takao ^e   Kusumoto, Yutaka ^a  

^a FUJI HEAVY INDUSTRIES LTD   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d National Hospital Organization Kasumigaura Medical Center   (Japan)

^e Yamato City Hospital   (Japan)

^f Social Ins Saitama Chuo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOZOPRAN; CEPHEM DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LOW BIRTH WEIGHT; MALE; NEWBORN; NEWBORN INFECTION; SEPTICEMIA; URINARY EXCRETION;

BACTERIAL INFECTIONS; CEPHALOSPORINS; FEMALE; HALF-LIFE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE;

EID: 0031419596     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. MIYAKE, A.; Y. YOSHIMURA, M. YAMAOKA, T. NISHIMURA, N. HASHIMOTO & A. IMADA: Stidies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7β-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3- (condensed-heterocyclic azolium)methyl cephalosporins including SCE-2787. J. Antibiotics 45: 709-720, 1992
2. IWAIII, T.; K. OKONOGI, T. YAMAZAKI, S. SIIIKI, M. KONDO, A. MIYAKE & A. IMADA: In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicr. Agents & Chemoth. 36: 1358-1366, 1992
3. NAKAO, M.; Y. NOJI, T. IWAHI & T. YAMAMAZAKI: Antibacterial properties of SCE-2787, a new cephem antibiotic. J. Antimicr. Chemoth. 29: 509-518, 1992
4. FUJII, R.; T. ABE, T. TAJIMA, I. TERASHIMA, H. MEGURO, S. NAKAZAWA, H. SATO, K. NIINOU, K. SUNAKAWA, T. YOKOTA, H. AKITA, S. IWATA, Y. SATO, Y. TOYONAGA, H. NAKAMURA, K. SEO, K. KAWAMURA, K. KUNO, K. ITO, N. IWAI, H. NAKAMURA, Y. TANEDA, M. SAKURAI, M. ITO, E. AZUMA, H. KAMIYA, K. KITAMURA, H. MIKAWA, H. KIMATA, T. NISHIMURA, K. TABUKI, S. AOKI, M. TAKAGI, Y. KOBAYASHI, T. HARUTA, K. OKURA, S. KUROKI, T. NISIIIO, H. MATSUDA, K. KIDA, Y. KAINOU, T. KURASHIGE, H. MORITA, Y. KURODA, E. SHIRAKAWA, T. OKAMOTO, T. SEKIOUCIII, Y. TSUJI, I. GONDO, N. KOBAYASHI, T. MOTOHIRO, Y.SAKATA, H. SASAKI, Y. YOSHINAGA & S. YAMADA: Pharmacokinetics and clinical effects of cefozopran in pédiatrie patients. Jap. J. Antibiotics 49: 17-33, 1996
5. Jap. J. Antibiotics 49: 678-702, 1996
6. Chemotherapy 41 (Suppl. 4): S135-S 141, 1993.
7. Jap. J. Antibiotics 49: 743-753, 1996
8. Chemotherapy 29: 76-79, 1981